| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1003034018 |
| P356 | DOI | 10.1007/S11926-013-0354-Y |
| P698 | PubMed publication ID | 23888363 |
| P2093 | author name string | Susan M Goodman | |
| C Ronald Mackenzie | |||
| P2860 | cites work | Acute-phase proteins and other systemic responses to inflammation | Q28296941 |
| Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery | Q28348438 | ||
| Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein | Q29547752 | ||
| Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort | Q31122937 | ||
| Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis | Q33686973 | ||
| Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis | Q33709082 | ||
| Cardiovascular morbidity and mortality in rheumatoid arthritis | Q33806651 | ||
| Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery | Q33845877 | ||
| Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
| Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 | ||
| Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study | Q34017775 | ||
| Factors that predict short-term complication rates after total hip arthroplasty | Q34037676 | ||
| Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus | Q34098573 | ||
| A population-based study of trends in the use of total hip and total knee arthroplasty, 1969-2008. | Q34165968 | ||
| Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity | Q34238357 | ||
| A population based assessment of the use of orthopedic surgery in patients with rheumatoid arthritis | Q34515099 | ||
| Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies | Q34889152 | ||
| Cardiovascular morbidity in psoriatic arthritis | Q60699917 | ||
| Risk factors for coronary artery disease in patients with systemic lupus erythematosus | Q67586359 | ||
| Ankylosing spondylitis: an important cause of severe disturbances of the cardiac conduction system. Prevalence among 223 pacemaker-treated men | Q70443395 | ||
| Cardiac conduction disturbances, an underestimated manifestation in ankylosing spondylitis. A 25-year follow-up study of 68 patients | Q70532418 | ||
| Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study | Q73106702 | ||
| Type and outcome of reconstructive surgery for different patterns of psoriatic arthritis | Q73715395 | ||
| Echocardiographic evidence of cardiac involvement in ankylosing spondylitis | Q74370268 | ||
| High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
| Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus | Q77909409 | ||
| Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study | Q79328295 | ||
| Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis | Q81412936 | ||
| The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis | Q82782197 | ||
| An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice | Q82839594 | ||
| Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study | Q83355833 | ||
| Mortality in Psoriatic Arthritis – A Single-center Study from the UK | Q84651042 | ||
| Factors Associated with Radiographic Spinal Involvement and Hip Involvement in Ankylosing Spondylitis | Q85092516 | ||
| Cardiac prognosis in noncardiac geriatric surgery | Q93642992 | ||
| Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty | Q94051069 | ||
| Comparison of postoperative values for C-reactive protein in minimally invasive and open lumbar spinal fusion surgery | Q35088647 | ||
| Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study | Q35605663 | ||
| Risk factors for cardiovascular complications following total joint replacement surgery | Q35667091 | ||
| Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty | Q35861919 | ||
| Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 | ||
| Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus | Q36235589 | ||
| Accelerated atherosclerosis in autoimmune rheumatic diseases | Q36318870 | ||
| Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. | Q36467247 | ||
| Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 | ||
| Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
| Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus | Q36968832 | ||
| Cardiovascular manifestations of rheumatologic diseases | Q36999472 | ||
| Aortic involvement in ankylosing spondylitis. | Q37272166 | ||
| Mortality in psoriatic arthritis. | Q37331985 | ||
| A meta-analysis of the utility of C-reactive protein in predicting early, intermediate-term and long term mortality and major adverse cardiac events in vascular surgical patients. | Q37422519 | ||
| Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies | Q37701610 | ||
| Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis. | Q37753594 | ||
| Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein | Q38478653 | ||
| Long-term results of total hip replacement in young patients who had ankylosing spondylitis. Eighteen to thirty-year results with survivorship analysis. | Q39453978 | ||
| Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030 | Q39513006 | ||
| Pulmonary injury in patients undergoing complex spine surgery | Q39715176 | ||
| Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality | Q39810945 | ||
| The one year incidence of postoperative myocardial infarction in an orthopedic population | Q39858686 | ||
| The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better | Q42935046 | ||
| Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis | Q43231832 | ||
| An analysis of joint replacement in patients with systemic lupus erythematosus | Q43256481 | ||
| The bimodal mortality pattern of systemic lupus erythematosus | Q43703475 | ||
| Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients. | Q43704586 | ||
| Systemic lupus erythematosus, rheumatoid arthritis, and postarthroplasty mortality: a cross-sectional analysis from the nationwide inpatient sample | Q43910223 | ||
| Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis | Q43948459 | ||
| The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study | Q45792532 | ||
| High prevalence of metabolic syndrome and cardiovascular risk factors in men with ankylosing spondylitis on anti-TNFalpha treatment: correlation with disease activity. | Q45994396 | ||
| Factors predicting complication rates following total knee replacement | Q46184054 | ||
| Subclinical carotid atherosclerosis in patients with psoriatic arthritis | Q46401856 | ||
| Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation | Q46414172 | ||
| Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus | Q46973423 | ||
| Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction | Q47273525 | ||
| Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery | Q49129962 | ||
| Predictors of radiographic severity and functional disability in Turkish patients with ankylosing spondylitis. | Q51519966 | ||
| Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. | Q53249650 | ||
| Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. | Q53725487 | ||
| P433 | issue | 9 | |
| P921 | main subject | cardiac surgery | Q235007 |
| rheumatism | Q684924 | ||
| P304 | page(s) | 354 | |
| P577 | publication date | 2013-09-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery | |
| P478 | volume | 15 |
| Q36968011 | Identification of novel urinary biomarkers for assessing disease activity and prognosis of rheumatoid arthritis |
| Q52349399 | Perioperative Management of Patients with Inflammatory Rheumatic Diseases Undergoing Major Orthopaedic Surgery: A Practical Overview. |
| Q57176362 | Total Joint Arthroplasty in Patients with Inflammatory Rheumatic Diseases |
| Q85797990 | [Perioperative management of patients with rheumatoid arthritis] |
Search more.